Back to Browse Journals » International Journal of Nephrology and Renovascular Disease » Volume 7

Obesity, hypertension, and chronic kidney disease

Authors Hall ME, do Carmo JM, da Silva AA, Juncos LA, Wang Z, Hall JE

Published Date February 2014 Volume 2014:7 Pages 75—88

DOI http://dx.doi.org/10.2147/IJNRD.S39739

Received 25 October 2013, Accepted 4 December 2013, Published 18 February 2014

Michael E Hall,1,2 Jussara M do Carmo,2 Alexandre A da Silva,2 Luis A Juncos,1,2 Zhen Wang,2 John E Hall2

1Department of Medicine, 2Department of Physiology and Biophysics, Mississippi Center for Obesity Research, University of Mississippi Medical Center, Jackson, MS, USA

Abstract: Obesity is a major risk factor for essential hypertension, diabetes, and other comorbid conditions that contribute to development of chronic kidney disease. Obesity raises blood pressure by increasing renal tubular sodium reabsorption, impairing pressure natriuresis, and causing volume expansion via activation of the sympathetic nervous system and renin-angiotensin-aldosterone system and by physical compression of the kidneys, especially when there is increased visceral adiposity. Other factors such as inflammation, oxidative stress, and lipotoxicity may also contribute to obesity-mediated hypertension and renal dysfunction. Initially, obesity causes renal vasodilation and glomerular hyperfiltration, which act as compensatory mechanisms to maintain sodium balance despite increased tubular reabsorption. However, these compensations, along with increased arterial pressure and metabolic abnormalities, may ultimately lead to glomerular injury and initiate a slowly developing vicious cycle that exacerbates hypertension and worsens renal injury. Body weight reduction, via caloric restriction and increased physical activity, is an important first step for management of obesity, hypertension, and chronic kidney disease. However, this strategy may not be effective in producing long-term weight loss or in preventing cardiorenal and metabolic consequences in many obese patients. The majority of obese patients require medical therapy for obesity-associated hypertension, metabolic disorders, and renal disease, and morbidly obese patients may require surgical interventions to produce sustained weight loss.

Keywords: visceral adiposity, type II diabetes, sodium reabsorption, glomerular filtration rate, sympathetic nervous system, renin-angiotensin-aldosterone system

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Critical care nephrology: could it be a model of multidisciplinarity in ICU nowadays for other sub-specialities – the jury is out

Honoré PM, Jacobs R, Joannes-Boyau O, De Waele E, De Regt J, Van Gorp V, Spapen HD

International Journal of Nephrology and Renovascular Disease 2014, 7:437-440

Published Date: 25 November 2014

Diagnosis and activity assessment of immunoglobulin A nephropathy: current perspectives on noninvasive testing with aberrantly glycosylated immunoglobulin A-related biomarkers

Suzuki Y, Suzuki H, Makita Y, Takahata A, Takahashi K, Muto M, Sasaki Y, Kelimu A, Matsuzaki K, Yanagawa H, Okazaki K, Tomino Y

International Journal of Nephrology and Renovascular Disease 2014, 7:409-414

Published Date: 30 October 2014

Optimal management of hyperphosphatemia in end-stage renal disease: an Indian perspective

Reddy YN, Sundaram V, Abraham G, Nagarajan P, Reddy YN

International Journal of Nephrology and Renovascular Disease 2014, 7:391-399

Published Date: 23 October 2014

The deleterious effects of arteriovenous fistula-creation on the cardiovascular system: a longitudinal magnetic resonance imaging study

Dundon BK, Torpey K, Nelson AJ, Wong DTL, Duncan RF, Meredith IT, Faull RJ, Worthley SG, Worthley MI

International Journal of Nephrology and Renovascular Disease 2014, 7:337-345

Published Date: 16 September 2014

Vascular access for hemodialysis: current perspectives

Santoro D, Benedetto F, Mondello P, Pipitò N, Barillà D, Spinelli F, Ricciardi CA, Cernaro V, Buemi M

International Journal of Nephrology and Renovascular Disease 2014, 7:281-294

Published Date: 8 July 2014

Analysis of serum phosphate control and phosphate binder utilization in incident hemodialysis patients

Farrand KF, Copley JB, Heise J, Fridman M, Keith MS, Poole L

International Journal of Nephrology and Renovascular Disease 2014, 7:261-269

Published Date: 5 July 2014